Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses and prices are as of 4 p.m. New York time.
Astellas Pharma Inc. , Japan’s second-biggest drugmaker, said it will pay Aveo Pharmaceuticals Inc. as much as $1.3 billion for the rights to develop and sell an experimental cancer drug that may compete with medicines from Pfizer Inc. and Bayer AG.
Optimer Pharmaceuticals Inc. won a U.S. panel’s unanimous backing for an antibiotic that fights a deadly bacterium linked to intestinal infections often caught in hospitals.
Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York.
"We believe shares are overvalued."
- George Farmer on Dec 06, 2010
Canaccord's Farmer Discusses Rise in Dendreon Stock